Frankfurt - Delayed Quote EUR
Serina Therapeutics Inc. R (2BO.F)
5.05
+0.39
+(8.37%)
At close: May 23 at 3:29:01 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
6,724
8,968
858.04
1,844.41
Total Liabilities Net Minority Interest
6,216
41,262
38,636.20
36,951.99
Total Equity Gross Minority Interest
508
-32,294
-37,778.16
-35,107.59
Total Capitalization
641
-29,311
-36,161.16
-35,107.59
Common Stock Equity
641
-32,294
-37,778.16
-35,107.59
Capital Lease Obligations
268
462
191.66
398.17
Net Tangible Assets
641
-32,294
-37,778.16
-35,107.59
Working Capital
3,310
6,206
110.89
958.79
Invested Capital
641
-29,311
-36,161.16
-35,107.59
Tangible Book Value
641
-32,294
-37,778.16
-35,107.59
Total Debt
268
3,445
1,808.66
398.17
Net Debt
--
--
1,084.77
--
Share Issued
9,422
8,413.89
8,413.89
8,413.89
Ordinary Shares Number
9,422
8,413.89
8,413.89
8,413.89
12/31/2021 - 5/17/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade